Anika Therapeutics ANIK Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $57.48M+3.3% | $55.63M-19.1% | $68.74M-20.4% | $86.33M-8.5% | ||
| $23.69M+0.4% | $23.59M-10.5% | $26.36M-23.9% | $34.63M+16.0% | ||
| —— | —— | $1.1M+70.6% | $647K-97.8% | ||
| $18.79M-21.1% | $23.81M-2.5% | $24.43M-38.6% | $39.77M+10.4% | ||
| $3.4M-38.1% | $5.49M-26.5% | $7.48M-15.3% | $8.83M+6.5% | ||
| $103.36M-9.1% | $113.65M-30.4% | $163.31M-3.7% | $169.55M+0.6% | ||
| $40.32M+3.4% | $38.99M+4.1% | $37.45M-22.4% | $48.28M+1.4% | ||
| $25.94M+1.0% | $25.69M-6.8% | $27.55M-10.2% | $30.7M+46.5% | ||
| $8.05M+13.0% | $7.13M-5.9% | $7.57M+3.2% | $7.34M-5.7% | ||
| $1.65M-33.7% | $2.49M-3.3% | $2.58M-96.5% | $74.6M-9.4% | ||
| $1.28M+8.3% | $1.18M-21.0% | $1.49M-76.9% | $6.44M-36.6% | ||
| $4.03M-28.7% | $5.66M-1.2% | $5.73M-66.8% | $17.22M-15.1% | ||
| $190.27M-6.2% | $202.74M-25.1% | $270.63M-22.5% | $349.13M+0.5% | ||
| $6.04M+7.5% | $5.62M-9.3% | $6.19M-31.7% | $9.07M+18.9% | ||
| $15.87M+17.0% | $13.57M-3.5% | $14.07M-25.3% | $18.84M+5.6% | ||
| $2.05M+7.0% | $1.92M+5.0% | $1.83M— | —— | ||
| —— | $665K— | —— | —— | ||
| $21.91M-6.0% | $23.31M-25.0% | $31.06M+11.3% | $27.91M-6.3% | ||
| $24.2M+0.8% | $24.01M-7.3% | $25.92M-10.1% | $28.82M+49.8% | ||
| $701K-9.2% | $772K+91.1% | $404K+1.5% | $398K-68.4% | ||
| $0— | $0— | $0— | $0— | ||
| $139K-3.5% | $144K-2.0% | $147K+0.7% | $146K+1.4% | ||
| $87.5M-1.6% | $88.96M-1.2% | $90.01M+10.9% | $81.14M+21.0% | ||
| $60.79M-15.2% | $71.67M-44.0% | $128.05M-39.2% | $210.72M-6.6% | ||
| -$4.96M+26.9% | -$6.78M-14.1% | -$5.94M+7.8% | -$6.44M-12.7% | ||
| $143.47M-6.8% | $153.99M-27.5% | $212.27M-25.7% | $285.56M-0.5% | ||
| $190.27M-6.2% | $202.74M-25.1% | $270.63M-22.5% | $349.13M+0.5% | ||
| $23.69M+0.4% | $23.59M-10.5% | $26.36M-23.9% | $34.63M+16.0% | ||
| $4.03M-28.7% | $5.66M-1.2% | $5.73M-66.8% | $17.22M-15.1% | ||
| $25.94M+1.0% | $25.69M-6.8% | $27.55M-10.2% | $30.7M+46.5% | ||
| $1.28M+8.3% | $1.18M-21.0% | $1.49M+2.8% | $1.45M— | ||
| $1.65M-33.7% | $2.49M-3.3% | $2.58M-96.5% | $74.6M-9.4% | ||
| $25.94M+1.0% | $25.69M-6.8% | $27.55M-10.2% | $30.7M+46.5% | ||
| $4.03M-28.7% | $5.66M-1.2% | $5.73M-66.8% | $17.22M-15.1% | ||
| $25.94M+1.0% | $25.69M-6.8% | $27.55M-10.2% | $30.7M+46.5% | ||
| $4.03M-28.7% | $5.66M-1.2% | $5.73M-66.8% | $17.22M-15.1% | ||
| $15.87M+17.0% | $13.57M-3.5% | $14.07M-25.3% | $18.84M+5.6% | ||
| $26.25M+1.2% | $25.93M-6.5% | $27.74M-3.7% | $28.82M+49.8% | ||
| $87.5M-1.6% | $88.96M-1.2% | $90.01M+10.9% | $81.14M+21.0% | ||
| $139K-3.5% | $144K-2.0% | $147K+0.7% | $146K+1.4% | ||
| $0— | $0— | $0— | $0— | ||
| $5.64M-5.0% | $5.94M— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Anika Therapeutics's total assets?
- Anika Therapeutics (ANIK) holds $179.4M in total assets, down 5.9% year over year.
- How much debt does Anika Therapeutics have?
- Anika Therapeutics carries $25.7M in total debt against $133.9M of shareholders' equity, a debt-to-equity ratio of 0.19.
- How much cash does Anika Therapeutics have?
- Anika Therapeutics holds $41.0M in cash and equivalents.
- Can Anika Therapeutics cover its short-term obligations?
- Its current ratio is 4.46 — current assets exceed current liabilities.
- Where does Anika Therapeutics's balance sheet data come from?
- Every line is extracted from Anika Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
